These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 12477503

  • 1. Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception.
    Mathur R, Hayman G, Bansal A, Jenkins J.
    Fertil Steril; 2002 Dec; 78(6):1154-8. PubMed ID: 12477503
    [Abstract] [Full Text] [Related]

  • 2. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome.
    Agrawal R, Tan SL, Wild S, Sladkevicius P, Engmann L, Payne N, Bekir J, Campbell S, Conway G, Jacobs H.
    Fertil Steril; 1999 Feb; 71(2):287-93. PubMed ID: 9988400
    [Abstract] [Full Text] [Related]

  • 3. Plasma levels of free vascular endothelial growth factor(165) (VEGF(165)) are not elevated during gonadotropin stimulation in in vitro fertilization (IVF) patients developing ovarian hyperstimulation syndrome (OHSS): results of a prospective cohort study with matched controls.
    Enskog A, Nilsson L, Brännström M.
    Eur J Obstet Gynecol Reprod Biol; 2001 Jun; 96(2):196-201. PubMed ID: 11384807
    [Abstract] [Full Text] [Related]

  • 4. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.
    Agrawal R, Conway G, Sladkevicius P, Tan SL, Engmann L, Payne N, Bekir J, Campbell S, Jacobs H.
    Fertil Steril; 1998 Oct; 70(4):651-8. PubMed ID: 9797093
    [Abstract] [Full Text] [Related]

  • 5. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization.
    Lee A, Christenson LK, Stouffer RL, Burry KA, Patton PE.
    Fertil Steril; 1997 Aug; 68(2):305-11. PubMed ID: 9240261
    [Abstract] [Full Text] [Related]

  • 6. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program.
    Artini PG, Fasciani A, Monti M, Luisi S, D'Ambrogio G, Genazzani AR.
    Fertil Steril; 1998 Sep; 70(3):560-4. PubMed ID: 9757891
    [Abstract] [Full Text] [Related]

  • 7. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration.
    Ludwig M, Jelkmann W, Bauer O, Diedrich K.
    Hum Reprod; 1999 Oct; 14(10):2437-41. PubMed ID: 10527964
    [Abstract] [Full Text] [Related]

  • 8. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.
    Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohí J, Simón C.
    Fertil Steril; 1999 Mar; 71(3):482-9. PubMed ID: 10065786
    [Abstract] [Full Text] [Related]

  • 9. Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome.
    D'Ambrogio G, Fasciani A, Monti M, Cattani R, Genazzani AR, Artini PG.
    Gynecol Endocrinol; 1999 Oct; 13(5):311-5. PubMed ID: 10599547
    [Abstract] [Full Text] [Related]

  • 10. Ovarian hyperstimulation syndrome and assisted reproductive technologies: why some and not others?
    McElhinney B, Ardill J, Caldwell C, Lloyd F, McClure N.
    Hum Reprod; 2002 Jun; 17(6):1548-53. PubMed ID: 12042276
    [Abstract] [Full Text] [Related]

  • 11. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
    Geva E, Amit A, Lessing JB, Lerner-Geva L, Daniel Y, Yovel I, Azem F, Barak V.
    J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
    Abramov Y, Barak V, Nisman B, Schenker JG.
    Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A rise of the serum level of von Willebrand factor occurs before clinical manifestation of the severe form of ovarian hyperstimulation syndrome.
    Ogawa S, Minakami H, Araki S, Ohno T, Motoyama M, Shibahara H, Sato I.
    J Assist Reprod Genet; 2001 Feb; 18(2):114-9. PubMed ID: 11285978
    [Abstract] [Full Text] [Related]

  • 17. Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome.
    Lainas GT, Kolibianakis EM, Sfontouris IA, Zorzovilis IZ, Petsas GK, Lainas TG, Tarlatzis BC.
    BJOG; 2014 Jun; 121(7):848-55. PubMed ID: 24621101
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S, Blockeel C, Tremellen KP, Fleming R, Tournaye H, Humaidan P, Nelson SM.
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [Abstract] [Full Text] [Related]

  • 20. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome.
    Chen CD, Wu MY, Chen HF, Chen SU, Ho HN, Yang YS.
    Fertil Steril; 1999 Aug; 72(2):286-92. PubMed ID: 10438997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.